DOCTEUR CHANTAL VERVLOESEM
0809.082.443 · rovalta.com · 27/09/2026
DOCTEUR CHANTAL VERVLOESEM
Financial year 2025 · Closed on 30/09/2025
Overview
Identity
Source · BCE/KBODOCTEUR CHANTAL VERVLOESEM is a Private limited company incorporated in 2009. Its registered office is in Ans.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0809.082.443
- Incorporation
- 14/01/2009
- Legal form
- Private limited company
- Registered office
- Rue de l'Yser 14
4430 Ans · WallonieSee on map - Contributed capital
- 12 400,00 €
- Latest accounts
- 30/09/2025
Joint committees (1)
- 200
Financials
Source · NBB, 16 filingsTrend over 16 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 229,1 k € | +28.3% | 178,6 k € | -2.8% | 183,7 k € | +3.4% | 177,7 k € | +0.5% | 176,9 k € |
| EBITDA | 226,8 k € | +28.5% | 176,4 k € | -2.8% | 181,5 k € | +3.2% | 175,8 k € | +0.5% | 174,9 k € |
| Operating result | 215,8 k € | +30.4% | 165,4 k € | -3.0% | 170,6 k € | +3.4% | 164,9 k € | +3.8% | 158,8 k € |
| Net result | 149,8 k € | +33.9% | 111,8 k € | -1.9% | 114 k € | +3.9% | 109,7 k € | +5.6% | 103,8 k € |
| Balance sheet | |||||||||
| Equity | 904,5 k € | +19.8% | 754,7 k € | +17.4% | 642,9 k € | +11.1% | 578,9 k € | +23.2% | 470 k € |
| Total assets | 949,6 k € | +19.1% | 797,3 k € | +11.9% | 712,7 k € | +11.0% | 642,2 k € | +10.1% | 583,4 k € |
| Cash | 772,8 k € | +25.8% | 614,5 k € | +19.8% | 512,9 k € | +18.9% | 431,3 k € | +17.4% | 367,2 k € |
| Debts | 43,1 k € | +11.3% | 38,7 k € | -43.8% | 68,9 k € | +9.8% | 62,7 k € | -44.3% | 112,5 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 30/09/20251 active · 3 ended
Active mandates
Ended mandates
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/10/2024 | 01/10/2023 | 01/10/2022 | 01/10/2021 | 01/10/2020 | 01/10/2019 |
| Closing of the financial year | 30/09/2025 | 30/09/2024 | 30/09/2023 | 30/09/2022 | 30/09/2021 | 30/09/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 29/04/2026 | 29/04/2025 | 25/03/2024 | 26/04/2023 | 26/04/2022 | 29/03/2021 |
| General meeting | 20/03/2026 | 21/03/2025 | 15/03/2024 | 16/03/2023 | 18/03/2022 | 19/03/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 16 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 30/09/2025 | 20/03/2026 | 29/04/2026 | French | |
| Micro model | 30/09/2024 | 21/03/2025 | 29/04/2025 | French | |
| Micro model | 30/09/2023 | 15/03/2024 | 25/03/2024 | French | |
| Micro model | 30/09/2022 | 16/03/2023 | 26/04/2023 | French | |
| Micro model | 30/09/2021 | 18/03/2022 | 26/04/2022 | French | |
| Micro model | 30/09/2020 | 19/03/2021 | 29/03/2021 | French | |
| Micro model | 30/09/2019 | 20/03/2020 | 30/04/2020 | French | |
| Micro model | 30/09/2018 | 15/03/2019 | 05/04/2019 | French | |
| Micro model | 30/09/2017 | 16/03/2018 | 26/04/2018 | French | |
| Abridged model | 30/09/2016 | 17/03/2017 | 18/04/2017 | French | |
| Abridged model | 30/09/2015 | 18/03/2016 | 31/03/2016 | French | |
| Abridged model | 30/09/2014 | 20/03/2015 | 09/04/2015 | French | |
| Abridged model | 30/09/2013 | 21/03/2014 | 02/04/2014 | French | |
| Abridged model | 30/09/2012 | 15/03/2013 | 12/04/2013 | French | |
| Abridged model | 30/09/2011 | 16/03/2012 | 11/04/2012 | French | |
| Abridged model | 30/09/2010 | 18/03/2011 | 28/04/2011 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 30/09/20251 active · 3 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025149,8 k €↑
- 2024Annual accounts 2024111,8 k €↓
- 2023Annual accounts 2023114 k €↑
- 2022Annual accounts 2022109,7 k €↑
- 2022Name changeDr Chantal VERVLOESEM
- 2021Annual accounts 2021103,8 k €↑
- 2021Name changeDOCTEUR CHANTAL VERVLOESEM
- 2020Annual accounts 202074,8 k €↑
- 2019Annual accounts 201965,2 k €↑
- 2018Annual accounts 201830,5 k €↑
- 2017Annual accounts 201728,9 k €↑
- 2016Annual accounts 201626,6 k €↓
- 2015Annual accounts 201531,4 k €↑
- 2014Annual accounts 201428,8 k €↑
- 2013Annual accounts 201313,2 k €↑
- 2012Annual accounts 201211,5 k €↓
- 2011Annual accounts 201115,3 k €↓
- 2010Annual accounts 201030,3 k €
- 14/01/2009IncorporationPrivate limited company